journal
https://read.qxmd.com/read/38628544/de-novo-inflammatory-bowel-disease-in-kidney-transplant-recipients-a-single-center-case-series-study
#1
JOURNAL ARTICLE
Masatomo Ogata, Masaki Kato, Takamasa Miyauchi, Marie Murata-Hasegawa, Yuko Sakurai, Kazunobu Shinoda, Hajime Yamazaki, Yugo Shibagaki, Masahiko Yazawa
INTRODUCTION: Gastrointestinal complications are common after solid organ transplantation. New-onset inflammatory bowel disease (IBD) after transplantation (de novo) is a major differential diagnosis of diarrhea after liver transplantation (LT) because of its high incidence in the field. However, the incidence of IBD after kidney transplantation (KT) remains unknown. METHODS: This case series comprised six de novo IBD patients who had undergone KT at our hospital from April 1998 to December 2020...
2024: Inflammatory Intestinal Diseases
https://read.qxmd.com/read/38590798/the-comprehensive-complication-index-in-ulcerative-colitis-a-comparison-with-the-clavien-dindo-classification
#2
JOURNAL ARTICLE
Yuki Horio, Motoi Uchino, Masataka Igeta, Kentaro Nagano, Kurando Kusunoki, Ryuichi Kuwahara, Toshiyuki Sato, Shinichiro Shinzaki, Hiroki Ikeuchi
INTRODUCTION: The comprehensive complication index (CCI), which weights all postoperative complications according to severity and integrates them into a single formula, has been reported as a new evaluation system. We aimed to compare the CCI with the Clavien-Dindo Classification (CDC) to patients with ulcerative colitis (UC). METHODS: Patients who underwent initial surgery for UC from April 2012 to March 2020 were included. The patients were classified into a length of stay (LOS) >30 days group or an LOS ≤30 days group...
2024: Inflammatory Intestinal Diseases
https://read.qxmd.com/read/38586860/a-retrospective-observational-study-of-patterns-of-biologic-drug-change-in-inflammatory-bowel-disease
#3
JOURNAL ARTICLE
Mahmoud Mosli
INTRODUCTION: Multiple therapies are currently available for inflammatory bowel disease (IBD); it is therefore crucial to understand patterns of drug change. This study aimed to examine the patterns of biological drug change and identify predictors of change in patients with IBD. METHODS: We performed a retrospective study of patients diagnosed with IBD who were initiated on treatment with biologics between June 2017 and October 2022. The study's primary objective was to describe biologic drug change patterns...
2024: Inflammatory Intestinal Diseases
https://read.qxmd.com/read/38544522/the-impacts-of-laparoscopic-restorative-proctocolectomy-for-ulcerative-colitis-systematic-review-and-meta-analysis
#4
REVIEW
Motoi Uchino, Hiroki Ikeuchi, Yuki Horio, Ryuichi Kuwahara, Kurando Kusunoki, Kentaro Nagano, Kei Kimura, Kozo Kataoka, Naohito Beppu, Masataka Ikeda
INTRODUCTION: Laparoscopic surgery (LAP) is now recognized as the standard procedure for colorectal surgery. However, the standard surgery for ulcerative colitis (UC) is total proctocolectomy with ileal pouch anal anastomosis (IPAA), which may be an overly complex procedure to complete laparoscopically. We conducted this systematic review and meta-analysis to evaluate the efficacy as well as the advantages and disadvantages of LAP-IPAA in patients with UC stratified by the outcome of interest...
2024: Inflammatory Intestinal Diseases
https://read.qxmd.com/read/38529083/laparoscopy-assisted-restorative-proctocolectomy-with-ileal-pouch-anal-anastomosis-in-middle-colic-artery-ligation-immediately-before-specimen-removal
#5
JOURNAL ARTICLE
Keiji Matsuda, Yojiro Hashiguchi, Tamuro Hayama, Kurara Hayashi, Toshiya Miyata, Kentaro Asako, Yoshihisa Fukushima, Ryu Shimada, Kensuke Kaneko, Keijiro Nozawa, Hiroki Ochiai, Takatsugu Yamamoto
INTRODUCTION: Restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) is the surgical procedure for ulcerative colitis (UC). Intestinal ischemia may occur if the main blood vessels are ligated at an early stage of this surgery. Considering that the blood flow in the large intestine can be maintained by preserving the middle colic artery, we have used a new IPAA method: ligating the middle colic artery immediately before removal of the specimens ("M-method"). Here, we evaluated the M-method's clinical outcomes...
2024: Inflammatory Intestinal Diseases
https://read.qxmd.com/read/38496725/dietary-perceptions-among-patients-with-crohn-s-disease-in-clinical-remission-comparison-with-an-era-preceding-the-availability-of-biologic-therapy
#6
JOURNAL ARTICLE
Makoto Tanaka, Aki Kawakami, Kayoko Sakagami, Hiroaki Ito
INTRODUCTION: Dietary temperance significantly affects the quality of life of patients with Crohn's disease (CD) and remains a major concern. However, perceptions of diet in remission may have changed from the era when treatment options were limited. Therefore, we compared the dietary perceptions and treatment of patients with CD in remission with previously published data from the time biologic therapy was not introduced. METHODS: We compared the data of 254 patients with CD in remission who completed a questionnaire survey in 2022 with those of 76 patients with CD in remission collected in 2003, when biologics were not used for maintenance therapy in Japan...
2024: Inflammatory Intestinal Diseases
https://read.qxmd.com/read/38344420/clinical-utilization-of-generic-drugs-and-biosimilars-for-ulcerative-colitis-treatment-insights-from-a-nationwide-database-study-in-japan
#7
JOURNAL ARTICLE
Rintaro Moroi, Yoichi Kakuta, Hiroshi Nagai, Yusuke Shimoyama, Takeo Naito, Hisashi Shiga, Yoshitaka Kinouchi, Atsushi Masamune
INTRODUCTION: Limited data exist regarding the prevalence and clinical practice involving generic drugs and biosimilars for treating ulcerative colitis (UC) in Japan. We aimed to clarify the clinical usage of these generic drugs and biosimilars for UC treatment in Japan using a nationwide database. METHODS: We collected data from 30,675 UC cases, along with their prescriptions for both generic drugs or biosimilars and their original counterparts, using a medical claim database provided by DeSC Healthcare, Inc...
2024: Inflammatory Intestinal Diseases
https://read.qxmd.com/read/38318202/rifaximin-treatment-of-collagenous-colitis-a-randomised-double-blind-placebo-controlled-trial
#8
JOURNAL ARTICLE
Sabine Becker, Louise B Grode, Ole K Bonderup
INTRODUCTION: Collagenous colitis (CC) is a disabling disease primarily affecting elderly women. Sparse, well-documented treatment modalities exist, except for budesonide. Long-term and repetitive treatment with budesonide is often necessary. Rifaximin is a poorly absorbed antibiotic with a positive modulatory effect on gut microbiota. In this randomised, double-blind, placebo-controlled single-centre trial, we test the effect of adding rifaximin in continuation to budesonide on relapse rates in CC...
2024: Inflammatory Intestinal Diseases
https://read.qxmd.com/read/38298887/white-blood-cell-counts-and-future-relapse-in-ulcerative-colitis-under-low-dose-thiopurine-treatment-in-real-world-practice-a-3-year-japanese-multi-center-retrospective-cohort-study
#9
JOURNAL ARTICLE
Hiroki Kiyohara, Hajime Yamazaki, Kei Moriya, Naohiko Akimoto, Shoichiro Kawai, Kento Takenaka, Tomohiro Fukuda, Keiichi Tominaga, Junji Umeno, Shinichiro Shinzaki, Yusuke Honzawa, Tomohisa Takagi, Hitoshi Ichikawa, Toshiyuki Endo, Ryo Ozaki, Akira Andoh, Katsuyoshi Matsuoka, Toshifumi Hibi, Taku Kobayashi
INTRODUCTION: Whether white blood cell (WBC) counts are predictors for the effectiveness of thiopurine treatment in ulcerative colitis (UC) has been inconclusive in previous studies with small sample sizes. We investigated the association between WBC counts and future relapses in UC patients in a large-scale multi-center study. METHODS: This retrospective cohort study enrolled a total of 723 UC patients in remission from 33 hospitals and followed up for 3 years...
2024: Inflammatory Intestinal Diseases
https://read.qxmd.com/read/38298886/crosstalk-between-micrornas-and-oxidative-stress-in-coeliac-disease
#10
REVIEW
Filippo Pelizzaro, Romilda Cardin, Giulia Sarasini, Milena Minotto, Chiara Carlotto, Matteo Fassan, Michela Palo, Fabio Farinati, Fabiana Zingone
MicroRNAs (miRNAs) are small, non-coding RNA molecules involved in regulating gene expression. Many studies, mostly conducted on pediatric patients, suggested that oxidative stress and several miRNAs may play an important role in coeliac disease (CeD) pathogenesis. However, the interplay between oxidative stress and miRNA regulatory functions in CeD remains to be clarified. In this review, we aimed to perform a literature review on the role of miRNAs and oxidative stress in adult CeD patients and to analyze their potential interactions...
2024: Inflammatory Intestinal Diseases
https://read.qxmd.com/read/38115912/pregnancy-outcomes-in-females-with-eosinophilic-esophagitis-a-nationwide-population-based-study
#11
JOURNAL ARTICLE
Lovisa Röjler, Amiko M Uchida, John J Garber, Olof Stephansson, Jonas Söderling, Bjorn Roelstraete, Jonas F Ludvigsson
INTRODUCTION: Eosinophilic esophagitis (EoE) is a chronic, allergic inflammatory disease of the esophagus. It has a peak incidence in the 2nd and 3rd decades of life. Despite this, little is known about pregnancy outcomes in patients with EoE. METHODS: Using a validated histopathologic and nationwide population-based cohort for the diagnosis of EoE, we examined maternal and fetal outcomes, with preterm birth as the primary outcome, in females with EoE compared to matched controls...
December 2023: Inflammatory Intestinal Diseases
https://read.qxmd.com/read/38115911/novel-utility-of-leucine-rich-alpha-2-glycoprotein-as-a-biomarker-in-ulcerative-colitis-a-predictor-of-endoscopic-remission-independent-of-symptoms
#12
JOURNAL ARTICLE
Tomoyuki Hayashi, Kazuya Kitamura, Masaaki Usami, Masaki Miyazawa, Masaki Nishitani, Akihiro Dejima, Makoto Yamamoto, Shotaro Kawase, Masaya Funaki, Noriaki Orita, Hidetoshi Nakagawa, Koki Morita, Noriho Iida, Akihiro Seki, Kouki Nio, Hidenori Kido, Hideo Takayama, Yuta Takeuchi, Shinya Yamada, Hajime Takatori, Mari Shimada, Hiroto Saito, Daisuke Yamamoto, Tadashi Toyama, Taro Yamashita
INTRODUCTION: Leucine-rich alpha-2-glycoprotein (LRG) is a potential biomarker for disease activity and reflects mucosal healing in patients with ulcerative colitis (UC). However, only a few studies have described a detailed sensitivity analysis of LRG in predicting mucosal healing in patients. This study aimed to evaluate the association between LRG and the endoscopic activity of UC and its predictability for mucosal healing and explore the utility and clinical application of LRG. METHODS: The diagnostic accuracy of biomarkers, including LRG, in predicting the endoscopic activity of UC was evaluated...
December 2023: Inflammatory Intestinal Diseases
https://read.qxmd.com/read/38115910/lifestyle-factors-and-silent-inflammatory-bowel-disease
#13
JOURNAL ARTICLE
Matthew D Coates, Shannon Dalessio, August Stuart, Vonn Walter, Andrew Tinsley, Kofi Clarke, Emmanuelle D Williams
INTRODUCTION: Hypoalgesic or silent inflammatory bowel disease (IBD) is a poorly understood condition that has been associated with poor clinical outcomes. There is evidence that lifestyle factors, including diet, exercise, and substance use can influence inflammatory activity and symptoms in IBD. It is unclear, though, whether these issues impact pain experience in IBD. We performed this study to evaluate the potential relationship between several key lifestyle factors and silent IBD...
December 2023: Inflammatory Intestinal Diseases
https://read.qxmd.com/read/38115909/real-world-data-on-short-term-and-long-term-treatment-results-of-ustekinumab-in-patients-with-steroid-resistant-dependent-ulcerative-colitis
#14
JOURNAL ARTICLE
Yoriaki Komeda, George Tribonias, Masashi Kono, Kohei Handa, Shunsuke Omoto, Mamoru Takenaka, Satoru Hagiwara, Naoko Tsuji, Naoshi Nishida, Hiroshi Kashida, Masatoshi Kudo
INTRODUCTION: Ustekinumab is an IgG1 kappa monoclonal antibody directed against the common p40 subunit of interleukin-12 and interleukin-23, which activate Th1- and Th17-mediated immune responses, respectively. It has proven efficacy for the treatment of moderate to severe ulcerative colitis (UC) in the UNIFI phase III clinical trial; however, data on its efficacy in the real world are limited. In this study, we aimed to assess the real-world efficacy of ustekinumab. METHODS: This observational study included 30 patients with UC who received ustekinumab from April 2020 to April 2022...
December 2023: Inflammatory Intestinal Diseases
https://read.qxmd.com/read/38098495/milan-ultrasound-criteria-predict-relapse-of-ulcerative-colitis-in-remission
#15
JOURNAL ARTICLE
Masa Maeda, Shintaro Sagami, Moyu Tashima, Yoko Yamana, Ryo Karashima, Yusuke Miyatani, Aya Hojo, Masaru Nakano, Toshifumi Hibi, Taku Kobayashi
INTRODUCTION: Bowel ultrasound is a noninvasive alternative to endoscopy for assessing the disease activity of ulcerative colitis; however, it is unclear whether bowel ultrasound can predict subsequent relapse from remission. MATERIALS AND METHODS: A retrospective cohort study enrolled patients with ulcerative colitis who underwent bowel ultrasound between July 2018 and July 2021 during clinical remission (patient-reported outcome-2 ≤1 and no rectal bleeding) for at least 3 months and were followed up for 1 year...
December 2023: Inflammatory Intestinal Diseases
https://read.qxmd.com/read/38098494/spirochetosis-mimicking-acute-appendicitis-clinical-report-and-review-of-the-literature
#16
Magdalena Lüthy, Samuel A Käser, Carolin Wagener, René Fahrner
INTRODUCTION: Intestinal spirochetosis is sometimes found by chance in histological specimen of routine endoscopies. There are only a few cases described in the literature that spirochetosis of the appendix was mimicking acute appendicitis. We present a case of pseudoappendicitis with the histological finding of spirochetes and review the current literature. CASE PRESENTATION: A 72-year-old woman presented with pain of the lower right abdomen and previous systemic corticoid therapy...
December 2023: Inflammatory Intestinal Diseases
https://read.qxmd.com/read/38098493/detection-rates-of-non-cavitary-epithelioid-cell-granuloma-by-gastrointestinal-biopsy-in-patients-with-treatment-na%C3%A3-ve-crohn-s-disease
#17
JOURNAL ARTICLE
Katsuya Endo, Yoko Kawakami, Yuki Yoshino, Shiho Kondo, Daisuke Fukushi, Atsuko Takasu, Takayuki Kogure, Morihisa Hirota, Kazuhiro Murakami, Kennichi Satoh
INTRODUCTION: Detecting non-cavitary epithelioid cell granuloma by gastrointestinal biopsy is important in the initial diagnosis of Crohn's disease (CD). In the present study, we aimed to determine the rate of granuloma detection by gastrointestinal biopsy according to the number of biopsies performed. METHODS: The present study included patients newly diagnosed with CD at our hospital between April 2017 and March 2023. During endoscopic examinations, biopsy specimens were taken from affected lesions...
December 2023: Inflammatory Intestinal Diseases
https://read.qxmd.com/read/38098492/effectiveness-and-factors-associated-with-response-to-golimumab-in-japanese-patients-with-ulcerative-colitis-in-real-clinical-practice-the-phoenix-study
#18
JOURNAL ARTICLE
Daisuke Hirayama, Satoshi Motoya, Toshifumi Ashida, Katsuyoshi Ando, Mikihiro Fujiya, Takahiro Ito, Shigeru Furukawa, Atsuo Maemoto, Takehiko Katsurada, Shiro Hinotsu, Noriko Sato, Naomi Mizuno, Yoshiko Ikawa, Hiroshi Nakase
INTRODUCTION: There have been limited reports on the clinical efficacy of golimumab (GLM) in Japanese patients with ulcerative colitis (UC) in real clinical practice. This study aimed to explore the real-life effectiveness and factors associated with response to GLM in Japanese patients with UC. METHODS: This observational, retrospective, multicenter study was conducted in hospitals with expertise in inflammatory bowel disease treatment. Sixty-three patients treated with GLM and active UC were included in the analysis...
December 2023: Inflammatory Intestinal Diseases
https://read.qxmd.com/read/37901343/assessing-the-clinical-and-endoscopic-efficacy-of-extended-treatment-duration-with-different-doses-of-mesalazine-for-mild-to-moderate-ulcerative-colitis-beyond-8-weeks-of-induction
#19
JOURNAL ARTICLE
Geert D'Haens, Ekaterina Safroneeva, Helen Thorne, Raphaël Laoun
INTRODUCTION: High-strength mesalazine formulations play an important role in providing a convenient option to increase the dose in ulcerative colitis (UC) patients and therefore avoiding the switch to another therapeutic class. Higher doses of mesalazine may be required during periods of remission in order to prevent relapse. AIM: The aim of the study was to investigate clinical outcomes of three mesalazine maintenance doses adapted for post induction response...
October 2023: Inflammatory Intestinal Diseases
https://read.qxmd.com/read/37901342/usefulness-of-serum-leucine-rich-alpha-2-glycoprotein-as-a-surrogate-marker-of-small-bowel-mucosal-injury-in-crohn-s-disease
#20
JOURNAL ARTICLE
Takuto Saiki, Takehiro Torisu, Akira Harada, Yu Kajiya, Yoshiaki Taniguchi, Shinji Morisaki, Junji Umeno, Hiroshi Suekane, Takanari Kitazono
INTRODUCTION: Although the importance of mucosal healing has been suggested in Crohn's disease, it is difficult to repeat endoscopy, especially for the entire small bowel. Recently, serum leucine-rich alpha-2 glycoprotein (LRG) has been used as a surrogate marker of endoscopy. However, few studies have investigated a correlation between LRG and mucosal injury of the entire small bowel. METHODS: We retrospectively analyzed the clinical data of 30 patients with Crohn's disease from June 2020 to August 2022 at Yamaguchi Red Cross Hospital...
October 2023: Inflammatory Intestinal Diseases
journal
journal
53313
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.